Dincer, N. Et Al. 2025. Lorlatinib-Induced Blindness: A Rare Entity. Practical Radiation Oncology , vol.15, no.2 , 120-123.

Dincer, N., Can, O., Demir, G., & ÖZYAR, E., (2025). Lorlatinib-Induced Blindness: A Rare Entity. Practical Radiation Oncology , vol.15, no.2, 120-123.

Dincer, Neris Et Al. "Lorlatinib-Induced Blindness: A Rare Entity," Practical Radiation Oncology , vol.15, no.2, 120-123, 2025

Dincer, Neris Et Al. "Lorlatinib-Induced Blindness: A Rare Entity." Practical Radiation Oncology , vol.15, no.2, pp.120-123, 2025

Dincer, N. Et Al. (2025) . "Lorlatinib-Induced Blindness: A Rare Entity." Practical Radiation Oncology , vol.15, no.2, pp.120-123.

@article{article, author={Neris Dincer Et Al. }, title={Lorlatinib-Induced Blindness: A Rare Entity}, journal={Practical Radiation Oncology}, year=2025, pages={120-123} }